Cardiovascular Pharmacological Actions of Rutaecarpine, a Quinazolinocarboline Alkaloid Isolated From Evodia rutaecarpa

Journal of Experimental and Clinical Medicine

Volumn 3, Issue 2, 2011, Pages 63-69

  Jayakumar, Thanasekaran ^a   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Platelets aggregation; Rutaecarpine; Thrombosis; Uterotonia; Vasodilation

Indexed keywords

ACETYLSALICYLIC ACID; CYTOCHROME P450; HEPARIN; LOSARTAN; PROSTAGLANDIN E; PROSTAGLANDIN SYNTHASE; RUTAECARPINE;

AREA UNDER THE CURVE; BLOOD PRESSURE REGULATION; BRAIN HYPOXIA; CARDIOVASCULAR EFFECT; DRUG MECHANISM; DRUG STRUCTURE; EVODIA; HUMAN; HYPERTENSION; LUNG EMBOLISM; NEUROPROTECTION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS; VASODILATATION;

EID: 79954819918     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jecm.2011.02.004     Document Type: Review

References (52)

1. Lee S.H., Son J.K., Jeong B.S., Jeong T.C., Chang H.W., Lee E.S., Jahng Y. Progress in the studies on rutaecarpine. Molecules 2008, 13:272-300.
2. Wang L., Hu C.P., Deng P.Y., Shen S.S., Zhu H.Q., Ding J.S., Tan G.S., et al. The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med 2005, 71:416-419.
3. Liao J.F., Chen C.F., Chow S.Y. Taiwan Yi Xue Hui Za Zhi 1981, 80:30-38.
4. Kobayashi Y., Hoshikuma K., Nakano Y., Yokoo Y., Kamiya T. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors. Planta Med 2001, 67:244-248.
5. Tang W., Eisenbrand G. Evodia rutaecarpa (Juss) Benth. Chinese Drugs of Plant Origin 1992, 509-514. Springer, Berlin, Germany. W. Tang, G. Eisenbrand (Eds.).
6. Chiou W.F., Sung Y.J., Liao J.F., Shum A.Y., Chen C.F. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod 1997, 60:708-711.
7. Chiou W.F., Ko H.C., Chen C.F., Chou C.J. Evodia rutaecarpa protects against circulation failure and organ dysfunction in endotoxaemic rats through modulating nitric oxide release. J Pharm Pharmacol 2002, 54:1399-1405.
8. Yarosh D.B., Galvin J.W., Nay S.L., Pena A.V., Canning M.T., Brown D.A. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J Dermatol Sci 2006, 42:13-21.
9. Chiou W.F., Shum A.Y., Liao J.F., Chen C.F. Studies of the cellular mechanisms underlying the vasorelaxant effects of rutaecarpine, a bioactive component extracted from an herbal drug. J Cardiovasc Pharmacol 1997, 29:490-498.
10. Sheu J.R., Kan Y.C., Hung W.C., Su C.H., Lin C.H., Lee Y.M., Yen M.H. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Thromb Res 1998, 92:53-64.
11. Hu C.P., Xiao L., Deng H.W., Li Y.J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med 2002, 68:705-709.
12. Yi H.H., Rang W.Q., Deng P.Y., Hu C.P., Liu G.Z., Tan G.S., Xu K.P., et al. Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP. Planta Med 2004, 70:1135-1139.
13. Hu C.P., Li N.S., Xiao L., Deng H.W., Li Y.J. Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats. Regul Pept 2003, 114:45-49.
14. Kametani T., Loc C.V., Higa T., Koizumi M., Ihara M., Fukumoto K. Iminoketene cycloaddition. 2. Total synthesis of arborine, glycosminine, and rutaecarpine by condensation of iminoketene with amides. J Am Chem Soc 1977, 99:2306-2309.
15. Ko H.C., Tsai T.H., Chou C.J., Hsu S.Y., Li S.Y., Chen C.F. High-performance liquid chromatographic determination of rutaecarpine in rat plasma: application to a pharmacokinetic study. J Chromatogr 1994, 655:27-31.
16. Lee S.K., Bista S.R., Jeong H., Kim D.H., Kang M.J., Jahng Y., Jeong T.C. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats. Arch Pharm Res 2007, 30(12):1629-1634.
17. Yuan S.F. General research on Evodia rutaecarpa [Juss.] Benth. Lishizhen Med Mater Med Res 2000, 11:281-282.
18. Deng P.Y., Ye F., Cai W.J., Tan G.S., Hu C.P., Deng H.W., Li Y.J. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 2004, 22:1819-1829.
19. Qin X.P., Zeng S.Y., Li D., Chen Q.Q., Luo D., Zhang Z., Hu G.Y., et al. Calcitonin gene related peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 2007, 50:654-659.
20. Wang G.J., Shan J., Pang P.K.T., Yang M.C.M., Chou C.J., Chen C.F. The vasorelaxing action of rutaecarpine: direct paradoxical effect on intracellular calcium concentration of vascular smooth muscle on endothelial cells. J Pharmacol Exp Ther 1996, 276:1016-1021.
21. Qin X.P., Zeng S.Y., Tian H.H., Deng S.X., Ren J.F., Zheng Y.B., Li D., et al. Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats. Clin Exp Pharmacol Physiol 2009, 36:319-324.
22. Ding J.S., Gao R., Li D., Peng J., Ran L.L., Li Y.J. Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats. Biopharm Drug Dispos 2008, 29:495-500.
23. Rees D.D., Palmer R.M.J., Hodson H.F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989, 96:418-424.
24. Martin W., Villani G.M., Furchgott R.F. Hemoglobin and methylene blue selectively inhibit relaxation of rabbit aorta by agents which increase cyclic GMP levels. Fed Proc 1984, 3:737. (Abstract).
25. Satoh H., Inui J. Endothelial cell-dependent relaxation and contraction induced by histamine in the isolated guinea-pig pulmonary artery. Eur J Pharmacol 1984, 97:321-324.
26. Vanhoutte P.M. Endothelium and control of vascular function. Hypertension 1989, 13:658-667.
27. Yamahara J., Yamada T., Kitani J., Naitoh Y., Fujimura H. Antianoxic action and active constituents of Evodiae Fructus. Chem Pharma Bull 1989, 37:1820-1822.
28. Hu C.P., Xiao L., Deng H.W., Li Y.J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med 2003, 69:125-129.
29. Tobe A., Egawa M., Hashimoto N. Antianoxic effect of 4-(o-benzlphenoxy)-N-methylbutylamine hydrochloride (MCI-2016). Nippon Yakurigaku Zasshi-Folia Pharmacologica Japonica 1983, 81:421-429.
30. Schubert J., Brill W.A. Antagonism of experimental cyanide toxicity in relation to the in vivo activity of cytochrome oxidase. J Pharmacol Exp Ther 1968, 162:352-359.
31. Sheu J.R., Yen M.H., Lee Y.M., Su C.H., Huang T.F. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta. Arterioscler Thromb Vasc Biol 1997, 17:3461-3468.
32. Hass W.K., Easton J.D., Adams H.P., Pryse-Philips W., Molony B.A., Anderson S., Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989, 321:501-507.
33. Sheu J.R., Chao S.H., Yen M.H., Huang T.F. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice. Thromb Haemost 1994, 72:617-621.
34. Sato M., Ohshima N. Hemodynamic at stenosis formed by growing platelet thrombi in mesenteric microvasculature of rat. Microvasc Res 1986, 31:66-76.
35. Nordoy A., Chandler A.B. Platelet thrombosis induced by adenosine diphosphate in the rat. Scand J Haematol 1964, 1:16-25.
36. Sheu J.R. Pharmacological effects of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Cardiovasc Drug Rev 1999, 17:237-245.
37. Sheu J.R., Hung W.C., Wu C.H., Yen M.H. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa on platelet plug formation in vivo. Br J Haematol 2000, 110:110-115.
38. Davi G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357:2482-2494.
39. Baglia A., Shrimpton C.N., Emsley J., Kitagawa K., Ruggeri Z.M., Lopez J.A., Walsh P.N. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet. J Biol Chem 2004, 279:49323-49329.
40. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
41. Brisson C., Azorsa D.O., Jennings L.K., Moog S., Cazenave J.P., Lanza F. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes. Histochem J 1997, 29:153-165.
42. Du X. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 2007, 14:262-269.
43. Landis R.C. Protease activated receptors: clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007, 21:103-113.
44. Thomas D.W., Mannon R.B., Mannon P.J., Latour A., Oliver J.A., Hoffman M., Smithies O., et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998, 102:994-2001.
45. Cherian T. Effect of papaya latex extract on gravid and non-gravid rat uterine preparations in vitro. J Ethanopharmacol 2000, 70:205-212.
46. Sewram V., Raynor M.W., Mulholland D.A., Raidoo D.M. The uterotonic activity of compounds isolated from the supercritical fluid extract of Ekebergia capensis. J Pharm Biomed Anal 2000, 24:33-45.
47. Woo H.G., Lee C.H., Noh M.S., Lee J.J., Jung Y.S., Baik E.J., Moon C.H., et al. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages. Planta Med 2001, 67:505-509.
48. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992, 267:259-264.
49. Lee E.S., Kim S.I., Lee S.H., Jeong T.C., Moon T.C., Chang H.W., Jahng Y. Synthesis and COX inhibitory activities of rutaecarpine derivatives. Bull Korean Chem Soc 2005, 26:1975-1980.
50. Lin J.H., Lu A.Y.H. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 1998, 35:361-390.
51. Ueng Y.F., Ko H.C., Chen C.F., Wang J.J., Chen K.T. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Life Sci 2002, 71:1267-1277.
52. Lee S.K., Kim N.H., Lee J., Kim D.H., Lee E.S., Choi H.G., Chang H.W., et al. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Planta Med 2004, 70:753-757.